Literature DB >> 16488536

Overproduction of PGE2 in peripheral blood monocytes of gastrointestinal cancer patients with mucins in their bloodstream.

Norio Yokoigawa1, Noriko Takeuchi, Munetoyo Toda, Mizue Inoue, Masaki Kaibori, Hidesuke Yanagida, Takaaki Inaba, Hironori Tanaka, Tokuhiro Ogura, Hideho Takada, Tadayoshi Okumura, A-Hon Kwon, Yasuo Kamiyama, Hiroshi Nakada.   

Abstract

When monocytes from healthy donors were cultured in the presence of sera from patients with gastrointestinal cancer, PGE2 production from the monocytes was elevated. Serum proteins were fractionated on Sepharose 4B and the inducing activity was found in the excluded fractions. By excluding some mucins from the serum, the inducing activity was reduced effectively. The activity was also reduced by adding binding inhibitors to the scavenger receptor. These results suggest that peripheral blood monocytes in epithelial cancer patients may be continuously stimulated by mucins in the bloodstream through the scavenger receptor, resulting in overproduction of PGE2.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16488536     DOI: 10.1016/j.canlet.2006.01.004

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Clinicopathological Features, Recurrence Patterns, and Prognosis of Pancreatic Adenocarcinoma with Normal Serum CA19-9. A Consecutive Series of 154 Cases from a Single Institute.

Authors:  Yajie Zhao; Chengfeng Wang
Journal:  J Gastrointest Surg       Date:  2019-04-03       Impact factor: 3.452

2.  Surgical resection of stage IV colorectal cancer and prognosis.

Authors:  Hiroshi Katoh; Keishi Yamashita; Yukihito Kokuba; Takeo Satoh; Heita Ozawa; Kazuhiko Hatate; Atsushi Ihara; Takatoshi Nakamura; Wataru Onosato; Masahiko Watanabe
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

3.  Preoperative platelet-lymphocyte ratio is an independent prognostic factor in ampullary carcinoma following pancreaticoduodenectomy.

Authors:  Wenqin Wang; Wei Liu; Ning Zhang; Xiaodong He
Journal:  Oncol Lett       Date:  2018-08-08       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.